The Asia Pacific Atherectomy Devices Market would witness market growth of 8.2% CAGR during the forecast period (2019-2025). The Asia Pacific Atherectomy Devices market is studied across the China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia Pacific. The China market dominated the Asia Pacific Atherectomy Devices Market by Country in 2018, and would continue to be a dominant market till 2025; thereby, achieving a market value of $57 Million by 2025, growing at a CAGR of 5.9 % during the forecast period. The India market is expected to witness a CAGR of 9.1% during (2019 - 2025). Additionally, The Japan market is expected to witness a CAGR of 9.2% during (2019 - 2025).
Growth in DAART interventions quantity is anticipated to boost atherectomy device revenues throughout the research. The United States in July 2015 Medicare & Medicaid Services Centers (CMS) have upgraded the Drug-Coated Balloons (DCBs) pass-through payment. This is projected to fuel the use of DCBs in office-based labs and ambulatory settings, and will immediately add to the increase in the number of procedures using atherectomy devices. A mixture of directional atherectomy with anti-restenosis therapy (DAART) with drug-coated balloons improves patency in lengthy lesions and severe calcification lesions. Combination instruments are available not only for rotational atherectomy machines but also for other atherectomy tools.
Over the coming years, Asia Pacific is expected to see the fastest development. Factors such as socioeconomic changes, smoking, unhealthy diet, liquor intake, and demographic aging have led to a rise in target diseases. In 2015, around 97 million individuals in the region were impacted by PAD. It is estimated that this number will reach 111 million in 2019. This shows the region’s enormous potential for market growth.
Based on Type, the market is segmented into Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy and Laser Atherectomy. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
Scope of the Study
- Directional Atherectomy
- Rotational Atherectomy
- Orbital Atherectomy and
- Laser Atherectomy
- South Korea
- Rest of Asia Pacific
- Cardiovascular Systems, Inc.
- Avinger, Inc.
- Straub Medical AG
- Boston Scientific Corporation
- Medtronic PLC (Covidien)
- Koninklijke Philips N.V.
- Cardinal Health, Inc. (Cordis)
- Terumo Corporation (Terumo IS)
- Abbott Laboratories
- B. Braun Melsungen AG
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free